Keyphrases
Technology Assessment
100%
Non-small Cell Lung Cancer (NSCLC)
100%
National Institutes of Health
100%
Cancer Drugs
100%
Targeted Therapy
33%
Targeted Immunotherapy
33%
Search Terms
16%
Time Method
16%
Health Status
16%
Reimbursement
16%
Survival Analysis
16%
Multiple Technologies
16%
Non-small Cell Lung Cancer Cells
16%
Lung Cancer Treatment
16%
Partitioned Survival Model
16%
Partitioned Survival Analysis
16%
Single Technology Appraisal
16%
Indirect Comparison
16%
Indirect Treatment Comparison
16%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Immunotherapy
28%
Targeted Therapy
28%
Cancer Therapy
14%
Survival Analysis
14%
Health Status
14%
Nursing and Health Professions
Non Small Cell Lung Cancer
100%
Immunotherapy
28%
Cancer Therapy
14%
Reimbursement
14%
Health Status
14%
Survival Analysis
14%
Biochemistry, Genetics and Molecular Biology
Targeted Therapy
100%
Health Status
50%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Immunotherapy
28%
Health Status
14%
Agricultural and Biological Sciences
Targeted Therapy
28%
Immunotherapy
28%